Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Hyperparathyroidism Rx from NPS effective in dialysis patients

Nov. 15, 1996

Latest findings on the diagnosis and treatment of erectile dysfunction

Nov. 15, 1996

New formulation of Leukine approved by FDA

Nov. 15, 1996

Obesity research collaboration announced by Novo Nordisk and Boehringer Ingelheim

Nov. 15, 1996

Symphony receives grant related to HMG-CoA inhibitors

Nov. 15, 1996

Green Cross describes inhibitors of lipid oxidation

Nov. 15, 1996

New hypolipidemic agents described by Nippon Zoki

Nov. 15, 1996

ADIR claims new agents for treating bone resorption

Nov. 15, 1996

Unprecedented efficacy and safety reported for Crinone in gynecological disorders

Nov. 8, 1996

MRC to coordinate large, long-term trial of HRT

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...